Latest Amphetamines Stories
DUBLIN, June 30, 2014 /PRNewswire/ -- Shire plc ("Shire" or the "Company") (LSE: SHP, NASDAQ: SHPG) announces that its Canadian subsidiary(1) has received assessments from
LEXINGTON, Massachusetts, June 25, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Judge Stanley R.
MIDDLESEX, N.J., June 4, 2014 /PRNewswire/ -- CorePharma, LLC ("CorePharma"), a developer, manufacturer, and marketer of targeted generic prescription pharmaceuticals, announced today that it
Genetic variants associated with enjoying the effects of d-amphetamine—the active ingredient in Adderall—are also associated with a reduced risk for developing schizophrenia and attention deficit hyperactivity disorder (ADHD).
Contest for adults who struggle with organization PHILADELPHIA, April 7, 2014 /PRNewswire/ -- Shire today announced the launch of the Organize Your Stuff contest, which is designed for adults
NEWPORT BEACH, Calif., April 2, 2014 /PRNewswire/ -- As warm weather, Spring Break, and the kick-off of seasonal music festivals is upon us, so are the dangers of so-called party drugs that
With up to 10 new designer drugs flooding streets every year, more education is needed to convey risks, especially among youth, say UAlberta researchers.
TORONTO, Feb. 25, 2014 /PRNewswire/ - Highland Therapeutics Inc.
DUBLIN, February 13, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces that Graham Hetherington, Chief Financial Officer (CFO), has notified the Board of
DUBLIN, February 6, 2014 /PRNewswire/ -- Shire plc (LSE: SHP, NASDAQ: SHPG) announces top-line results from two pivotal Phase 3 investigational studies evaluating the efficacy
- Withering but not falling off, as a blossom that persists on a twig after flowering.